ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pulmonary"

  • Abstract Number: 1855 • ACR Convergence 2021

    Up-regulation of TNFα Gene in Peripheral Blood Is Useful for Predicting the Development of Exercise-induced Pulmonary Hypertension, Which Is Early Stage of Pulmonary Vascular Disease Associated with Systemic Sclerosis

    Yoshinobu Koyama1, Yoshiharu Sato2, Tatsuma Shoji2, Soichiro Fuke1, Takatsune Umayahara1 and Moe Sakamoto1, 1Japanese Red Cross Okayama Hospital, Okayama, Japan, 2DNA Chip Research Inc, Tokyo, Japan

    Background/Purpose: Pulmonary hypertension (PH) is prominent as a vascular involvement of systemic sclerosis (SSc), which remains a leading cause of death in spite of current…
  • Abstract Number: 0084 • ACR Convergence 2021

    COVID-19 Pneumonia in Two Hospitals: Similar Outcomes Despite Differential Use of Tocilizumab

    Leanna Wise1, Lauren Mathias2, Wendy Mack2, Aarya Kafi3, Yash Kothari2, Omkar Rao3 and William Stohl4, 1LAC+USC/Keck Medicine of USC, Pasadena, CA, 2University of Southern California, Los Angeles, CA, 3University of California San Diego, San Diego, CA, 4University of Southern California Keck School of Medicine, Los Angeles, CA

    Background/Purpose: A substantial number of patients with COVID-19 pneumonia develop a hyperinflammatory state. The anti-IL-6 receptor (IL-6R) mAb tocilizumab (TCZ) has been used in such…
  • Abstract Number: 0150 • ACR Convergence 2021

    Clinical Characteristics and Quantitative CT Findings in Connective Tissue Disease-Associated Interstitial Lung Disease

    Sirus Jesudasen1, Badar Patel2, Kristin D'Silva1, Pietro Nardelli2, Ruben San José Estépar2, George Washko2, Raúl San José Estépar2, Farbod Rahaghi2 and Sydney Montesi1, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Precapillary Pulmonary Hypertension (PPH) is a known complication of connective tissue disease-associated interstitial lung disease (CTD-ILD) but at present requires right heart catheterization (RHC)…
  • Abstract Number: 0152 • ACR Convergence 2021

    Deep Learning-Derived Chest Radiograph Scores in COVID-19 in Rheumatic Disease Patients versus General Population Comparators

    Naomi Patel1, Kristin D'Silva1, Matthew Li1, Tiffany Hsu2, Michael Di Iorio3, Xiaoqing Fu1, Claire Cook4, Lauren Prisco5, Lily Martin6, Kathleen Vanni6, Alessandra Zaccardelli6, Yuqing Zhang7, Jayashree Kalpathy-Cramer1, Jeffrey Sparks6 and Zachary Wallace8, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Jamaica Plain, MA, 3Brigham and Women's Hospital, Brookline, MA, 4Division of Rheumatology, Allergy, and Immunology, Mass General Hospital, Boston, MA, 5Brigham and Women's Hospital, Pound Ridge, MA, 6Brigham and Women's Hospital, Boston, MA, 7Massachusetts General Hospital, Quincy, MA, 8Massachusetts General Hospital, Newton, MA

    Background/Purpose: Patients with rheumatic diseases and COVID-19 may have higher risk of mechanical ventilation than those without rheumatic diseases. We compared COVID-19 lung disease between…
  • Abstract Number: 0288 • ACR Convergence 2021

    Demographic, Lifestyle, and Clinical Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies

    Gregory McDermott1, Ritu Gill2, Staci Gagne3, Suzanne Byrne3, Weixing Huang3, Lauren Prisco4, Alessandra Zaccardelli3, Lily Martin3, Nancy Shadick5, Paul Dellaripa3, Tracy Doyle6 and Jeffrey Sparks3, 1Brigham and Women's Hospital, Brookline, MA, 2Beth Israel Deaconess Medical Center, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4Brigham and Women's Hospital, Pound Ridge, MA, 5Brigham & Women's Hospital, Boston, MA, 6Brigham and Women's Hospital, West Roxbury, MA

    Background/Purpose: Bronchiectasis is a known extra-articular manifestation of rheumatoid arthritis (RA) characterized by bronchial damage and excessive mucus production that predispose patients to risk of…
  • Abstract Number: 0290 • ACR Convergence 2021

    Prevalence and Predictors of Mortality in Rheumatoid Arthritis-Related Lung Disease: Results from a Single Center Study

    Didem Sahin Eroglu1, Anil Colaklar2, Serdar Baysal3, Murat Torgutalp1, Asaf Baygul4, Serdar Sezer1, Emine Aydemir Guloksuz1, Mehmet Yuksel1, Mucteba Yayla1, Emine Uslu yurteri5, Caglar Uzun2, Ozlem Ozdemir kumbasar4, Murat Turgay1, Kinikli Gulay1 and Askin Ates1, 1Ankara University Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 2Ankara University Faculty of Medicine, Department of Radiology, Ankara, Turkey, 3Ankara University Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey, 4Ankara University Faculty of Medicine, Department of Pulmonology, Ankara, Turkey, 5Hatay Training and Research Hospital, Hatay, Turkey

    Background/Purpose: Rheumatoid arthritis-related lung disease (RA-LD) is a common manifestation of rheumatoid arthritis (RA) and associated with excess mortality. Many studies to date were focused…
  • Abstract Number: 0291 • ACR Convergence 2021

    IgA Anti-Cyclic Citrullinated Peptide Antibodies in Bronchoalveolar Lavage Fluid from Patients with Idiopathic Pulmonary Fibrosis Are Associated with Reduced Mortality

    Scott Matson1, Candace Cephers2, Timothy Wilson3, Valerie Minarchick3, Kevin Brown4, Joshua Solomon4 and Kristen Demoruelle5, 1University of Kansas, Kansas City, MO, 2St Joseph Hospital, Internal Medicine, Denver, CO, 3University of Colorado, Denver, CO, 4National Jewish Health, Denver, CO, 5University of Colorado Anschutz Medical Campus, Aurora, CO

    Background/Purpose: Idiopathic pulmonary fibrosis (IPF) is a form of interstitial lung disease (ILD) that shares many clinical features with rheumatoid arthritis (RA) associated ILD. Our…
  • Abstract Number: 0497 • ACR Convergence 2021

    Efficacy in Patient Subgroups in the INCREASE Trial, a Phase III Trial to Evaluate Inhaled Treprostinil in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease

    Victor Tapson1, Steven Nathan2, Reda Girgis3, James Runo4, Remzi Bag5, Arunabh Talwar6, Peter Smith7, Lisa Edwards7, Christine Park7 and Aaron Waxman8, 1Cedars-Sinai, Los Angeles, CA, 2Inova Fairfax, Falls Church, VA, 3Michigan State University, Lansing, MI, 4University of Wisconsin, Madison, WI, 5University of Chicago, Chicago, IL, 6Hofstra Northwell School of Medicine, Hempstead, NY, 7United Therapeutics Corporation, Durham, NC, 8Brigham and Women's Hospital, Boston, MA

    Background/Purpose: INCREASE was a 16-week trial evaluating the safety and efficacy of inhaled treprostinil (iTRE) in patients with pulmonary hypertension associated with interstitial lung disease…
  • Abstract Number: L04 • ACR Convergence 2020

    Influenza Adverse Events in Patients with Rheumatoid Arthritis in the Tofacitinib Clinical Program

    Kevin L Winthrop1, Arne Yndestad2, Dan Henrohn3, Hyejin Jo4, Sara Marsal5, Maria Galindo6, Annette Diehl7, Andrea B Shapiro8 and Stanley B Cohen9, 1Oregon Health & Science University, Portland, OR, 2Pfizer Inc, Oslo, Norway, 3Pfizer Inc, Sollentuna, Sweden, 4Syneos Health, Raleigh, NC, 5Vall d’Hebron Hospital, Barcelona, Spain, 6Rheumatology Unit, Hospital Universitario 12 de Octubre, Madrid, Spain, 7Pfizer Inc, Collegeville, PA, 8Pfizer Inc, Peapack, NJ, 9Metroplex Clinical Research Center, Dallas, TX

    Background/Purpose: Patients (pts) with RA have increased susceptibility to seasonal influenza and its complications.1 The COVID-19 pandemic highlights the need to understand acute respiratory RNA…
  • Abstract Number: 0387 • ACR Convergence 2020

    Altered Iron Homeostasis and Pulmonary Haemodynamics in Systemic Sclerosis Associated Pulmonary Arterial Hypertension

    Alper Sari1, Christopher Denton2, Svetlana Nihtyanova3, Benjamin Schreiber4 and Voon Ong3, 1Hacettepe University, Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Ankara, Turkey, 2University College London, London, United Kingdom, 3Centre for Rheumatology, Royal Free Campus, UCL Division of Medicine, UK, London, United Kingdom, 4UCL, London, United Kingdom

    Background/Purpose: Iron deficiency (ID) is more frequent in systemic sclerosis (SSc) patients with pulmonary hypertension (PH) than those without and associated with worse prognosis. There…
  • Abstract Number: 1378 • ACR Convergence 2020

    Understanding Diagnostic Pathways in Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

    Shervin Assassi1, Nan Shao2, Ziwei Yin2, Elizabeth Volkmann3, Donald Zoz2 and Thomas Leonard2, 1University of Texas Houston McGovern Medical School, Division of Rheumatology and Clinical Immunogenetics, Houston, TX, 2Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, 3University of California, Los Angeles, Los Angeles, CA

    Background/Purpose: Interstitial lung disease (ILD) is a common manifestation of SSc. SSc-ILD is usually detected in a patient known to have SSc, but ILD may…
  • Abstract Number: 0392 • ACR Convergence 2020

    Prevalence and Survival of Systemic Sclerosis (SSc) and Associated Interstitial Lung Disease (ILD) in Ontario, Canada over 10 Years

    Janet Pope1, Kobina Quansah2, Martin Kolb3, Jason Flavin4, Hassan Shazia5 and Soo Jin Seung5, 1Department of Medicine, University of Western Ontario, St. Joseph's Health Centre, London, ON, Canada, 2Boehringer Ingelheim (Canada) Limited, Burlington, ON, Canada, 3McMaster University and Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamliton, ON, Canada, 4Boehringer Ingelheim, Corporate Headquarters, Burlington, ON, Canada, 5HOPE Research Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disease characterized by skin thickening, vascular lesions and fibrotic changes in various organs, mainly the lungs, heart, intestinal…
  • Abstract Number: 1381 • ACR Convergence 2020

    Real-World Mono-, Double and Triple Combination Treatment Patterns with Macitentan in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Evidence from the Combined OPUS/OrPHeUS Dataset

    Matthew Lammi1, Kelly Chin2, Nick H. Kim3, Vallerie McLaughlin4, Roham Zamanian5, Megan Flynn6, Sandrine Leroy7, Rose Ong7, Graham Wetherill7 and Richard Channick8, 1Lousiana State University Health Sciences Center, New Orleans, LA, 2UT Southwestern Medical Center, Dallas, TX, 3University of California San Diego, La Jolla, CA, 4University of Michigan, Ann Arbor, MI, 5Stanford University School of Medicine, Stanford, CA, 6Actelion Pharmaceuticals US, Inc., South San Francisco, CA, 7Actelion Pharmaceuticals Ltd, Allschwil, Switzerland, 8University of California Los Angeles, Los Angeles

    Background/Purpose: Patients with PAH-CTD have a worse prognosis than patients with most other PAH etiologies. The OPsumit® USers (OPUS) Registry and OPsumit® Historical USers (OrPHeUS)…
  • Abstract Number: 0398 • ACR Convergence 2020

    Chest CT Ordering Practices at Expert Scleroderma Centers in the United States

    Elana Bernstein1, John VanBuren2, Shervin Assassi3, Flavia Castelino4, Lorinda Chung5, Chase Correia6, Luke Evnin7, Tracy Frech8, Emily Startup2, Jessica Gordon9, Faye Hant10, Laura Hummers11, Nora Sandorfi12, Ami Shah13, Victoria Shanmugam14, Virginia Steen15 and Dinesh Khanna16, 1Columbia University, New York, NY, 2University of Utah, Salt Lake City, UT, 3University of Texas Houston McGovern Medical School, Division of Rheumatology and Clinical Immunogenetics, Houston, TX, 4Massachusetts General Hospital/Harvard Medical School, Boston, MA, 5Stanford University School of Medicine and Palo Alto VA Health Care System, Palo Alto, CA, 6Northwestern University, Chicago, IL, 7Scleroderma Research Foundation, Brisbane, CA, 8University of Utah and Salt Lake Veterans Affair Medical Center, Salt Lake City, UT, 9Hospital for Special Surgery, New York, NY, 10Medical University of South Carolina, Charleston, SC, 11Johns Hopkins Univerisity, Ellicott City, MD, 12University of Pennsylvania, Philadelphia, PA, 13Johns Hopkins University School of Medicine, Ellicott City, MD, 14The George Washington University, Washington, DC, 15Division of Rheumatology, Department of Medicine, MedStar Georgetown University Hospital, Washington, DC, 16University of Michigan, Ann Arbor, MI

    Background/Purpose: Interstitial lung disease (ILD) is the leading cause of death in patients with systemic sclerosis (SSc). Although pulmonary function tests (PFTs) are commonly used…
  • Abstract Number: 1430 • ACR Convergence 2020

    The Role of Lung Biopsy in Pediatric ANCA-associated Vasculitis

    Edouard Sayad1, Tiphanie Vogel1, David Moreno McNeill1, Nahir Cortes-Santiago1, David Spielberg1, Kalyani Patel1 and Manuel Silva Carmona1, 1Baylor College of Medicine/Texas Children's Hospital, Houston, TX

    Background/Purpose: Anca-associated vasculitis (AAV) is characterized by vascular inflammation in multiple organs. The diagnosis can be made clinically using a number of different criteria. The…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology